Skip to main content
Micro-Tech (Nanjing) Co.,Ltd logo

Micro-Tech (Nanjing) Co.,Ltd — Investor Relations & Filings

Ticker · 688029 ISIN · CNE100003MG1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2021-01-25 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688029

About Micro-Tech (Nanjing) Co.,Ltd

https://www.micro-tech.com.cn/

Micro-Tech (Nanjing) Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical devices. The company focuses on providing advanced solutions for gastroenterology, respiratory medicine, and orthopedics. Its product portfolio includes a wide range of endoscopic diagnostic and therapeutic tools such as biopsy forceps, disposable hemoclips, biliary and esophageal stents, and specialized instruments for Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). Micro-Tech emphasizes innovation and quality, maintaining international certifications to serve a global healthcare market. By integrating precision engineering with clinical needs, the company aims to improve patient outcomes and procedural efficiency for medical professionals worldwide.

Recent filings

Filing Released Lang Actions
江苏新高的律师事务所关于南微医学科技股份有限公司2021年第一次临时股东大会的见证法律意见书
Regulatory Filings
2021-01-25 Chinese
2021年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled '2021 年第一次临时股东大会会议资料' which translates to '2021 First Extraordinary General Meeting (EGM) Meeting Materials'. It contains detailed information about the meeting agenda, voting procedures, meeting rules, and specific proposals to be discussed and voted on during the meeting. It is not a report of financial results or an announcement of voting results, but rather the materials prepared for the shareholders to review before or during the meeting. The document length is 3884 characters, which is relatively short but contains substantive meeting materials rather than just an announcement or a brief notice. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting.
2021-01-17 Chinese
关于重大事件的进展情况说明公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from the company 南微医学科技股份有限公司 regarding a significant event related to a COVID-19 positive test in their raw material warehouse. It details the company's response measures, testing results, and ongoing cooperation with government authorities. The document is short (701 characters) and focuses on a specific incident and its progress, not on financial results, management changes, or shareholder votes. It does not contain financial data or detailed report content. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a significant event affecting the company, without fitting into more specific categories like Annual Report, Earnings Release, or Legal Proceedings Report.
2021-01-10 Chinese
第二届监事会第十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of 南微医学科技股份有限公司 regarding several agenda items including related party transactions, cash management, and hedging business. It includes voting results and confirms compliance with laws and company regulations. The document is short (1355 characters) and does not contain financial statements or detailed financial data. It is an official announcement of board meeting resolutions rather than a full management report or financial report. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2021-01-10 Chinese
南京证券股份有限公司关于南微医学科技股份有限公司2021年度日常关联交易额度预计事项以及开展外汇衍生品交易业务事项的核查意见
Regulatory Filings Classification · 95% confidence The document is a detailed report from Nanjing Securities Co., Ltd. regarding the 2021 annual expected daily related-party transaction limits and the review opinions on the hedging business of Nanwei Medical Technology Co., Ltd. It includes detailed financial figures, transaction categories, related party information, risk analysis, and procedural approvals. The content is substantive and specific to the company's financial and operational activities for the year 2021, focusing on related-party transactions and hedging activities. It is not a brief announcement or a certification letter but a comprehensive report on these matters. This fits best under the category of Regulatory Filings (RNS) because it is a regulatory disclosure document related to related-party transactions and hedging business, which does not fall under other more specific categories like Annual Report or Audit Report. The document length is 4643 characters, which is substantial but not a full annual or interim report. Therefore, the classification is RNS with high confidence.
2021-01-08 Chinese
关于开展套期保值业务的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from the company 南微医学科技股份有限公司 regarding the commencement of hedging (套期保值) business to manage foreign exchange risk. It details the purpose, scope, risk analysis, risk control measures, and opinions from independent directors, the supervisory board, and the sponsoring institution. The document is a formal announcement of a new financial activity (hedging business) approved by the board, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or results but rather a description and approval of a capital/financial activity related to risk management. Therefore, it fits best under Capital/Financing Update (CAP). The document length is 2228 characters, which is consistent with an announcement rather than a full report.
2021-01-08 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.